Cargando…

Multipredictor risk models for predicting individual risk of Alzheimer’s disease

BACKGROUND: Early prevention of Alzheimer’s disease (AD) is a feasible way to delay AD onset and progression. Information on AD prediction at the individual patient level will be useful in AD prevention. In this study, we aim to develop risk models for predicting AD onset at individual level using o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hou, Xiao-He, Suckling, John, Shen, Xue-Ning, Liu, Yong, Zuo, Chuan-Tao, Huang, Yu-Yuan, Li, Hong-Qi, Wang, Hui-Fu, Tan, Chen-Chen, Cui, Mei, Dong, Qiang, Tan, Lan, Yu, Jin-Tai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614397/ https://www.ncbi.nlm.nih.gov/pubmed/37904154 http://dx.doi.org/10.1186/s12967-023-04646-x

Ejemplares similares

Associations of Alzheimer’s disease risk variants with gene expression, amyloidosis, tauopathy, and neurodegeneration
por: Tan, Meng-Shan, et al.
Publicado: (2021)

Machine Learning Reveals a Multipredictor Nomogram for Diagnosing the Alzheimer’s Disease Based on Chemiluminescence Immunoassay for Total Tau in Plasma
por: Zhang, Lingyu, et al.
Publicado: (2022)

A multipredictor model to predict the conversion of mild cognitive impairment to Alzheimer’s disease by using a predictive nomogram
por: Huang, Kexin, et al.
Publicado: (2019)

Longitudinal trajectories of Alzheimer’s ATN biomarkers in elderly persons without dementia
por: Tan, Meng-Shan, et al.
Publicado: (2020)

Subtle cognitive impairment as a marker of Alzheimer's pathologies and clinical progression in cognitively normal individuals
por: Shen, Xue‐Ning, et al.
Publicado: (2021)

High pulse pressure is a risk factor for prodromal Alzheimer’s disease: a longitudinal study
por: Shi, Wen-Yan, et al.
Publicado: (2020)

Disease trajectories in elders with suspected non-Alzheimer’s pathophysiology and its comparison with Alzheimer’s disease pathophysiology: a longitudinal study
por: Li, Jie-Qiong, et al.
Publicado: (2023)

Clinical and biomarker trajectories in sporadic Alzheimer's disease: A longitudinal study
por: Wang, Hui‐Fu, et al.
Publicado: (2020)

Metabolically healthy obesity reduces the risk of Alzheimer’s disease in elders: a longitudinal study
por: Ma, Ling-Zhi, et al.
Publicado: (2019)

Genetically determined blood pressure, antihypertensive medications, and risk of Alzheimer’s disease: a Mendelian randomization study
por: Ou, Ya-Nan, et al.
Publicado: (2021)

Genetically determined low income modifies Alzheimer’s disease risk
por: Wang, Rong-Ze, et al.
Publicado: (2021)

Nutrition and the Risk of Alzheimer's Disease
por: Hu, Nan, et al.
Publicado: (2013)

Staging tau pathology with tau PET in Alzheimer’s disease: a longitudinal study
por: Chen, Shi-Dong, et al.
Publicado: (2021)

Discordant Alzheimer's neurodegenerative biomarkers and their clinical outcomes
por: Guo, Yu, et al.
Publicado: (2020)

Herpesvirus infections and Alzheimer’s disease: a Mendelian randomization study
por: Huang, Shu-Yi, et al.
Publicado: (2021)

Association of cerebrospinal fluid neurogranin levels with cognition and neurodegeneration in Alzheimer’s disease
por: Xue, Mei, et al.
Publicado: (2020)

Longitudinal plasma phosphorylated tau 181 tracks disease progression in Alzheimer’s disease
por: Chen, Shi-Dong, et al.
Publicado: (2021)

Characterization of Alzheimer’s tau biomarker discordance using plasma, CSF, and PET
por: Guo, Yu, et al.
Publicado: (2021)

TREML2 Mutation Mediate Alzheimer’s Disease Risk by Altering Neuronal Degeneration
por: Song, Ya-Nan, et al.
Publicado: (2019)

Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer’s amyloid, tau and FDG PET status
por: Shen, Xue-Ning, et al.
Publicado: (2021)

Apolipoprotein B/AI ratio as an independent risk factor for intracranial atherosclerotic stenosis
por: Sun, Yan, et al.
Publicado: (2019)

The dynamics of plasma biomarkers across the Alzheimer’s continuum
por: Guo, Yu, et al.
Publicado: (2023)

Association of serum Apolipoprotein B with cerebrospinal fluid biomarkers of Alzheimer’s pathology
por: Hu, Hao, et al.
Publicado: (2020)

NME8 rs2718058 polymorphism with Alzheimer's disease risk: a replication and meta-analysis
por: Liu, Shu-Lei, et al.
Publicado: (2016)

A panel of blood lipids associated with cognitive performance, brain atrophy, and Alzheimer's diagnosis: A longitudinal study of elders without dementia
por: Ma, Ya‐Hui, et al.
Publicado: (2020)

FERMT2 rs17125944 polymorphism with Alzheimer's disease risk: a replication and meta-analysis
por: Zhang, Qiu-Yue, et al.
Publicado: (2016)

Association between methylation of BIN1 promoter in peripheral blood and preclinical Alzheimer’s disease
por: Hu, Hao, et al.
Publicado: (2021)

Late-life obesity is a protective factor for prodromal Alzheimer’s disease: a longitudinal study
por: Sun, Zhen, et al.
Publicado: (2020)

Elevated homocysteine as an independent risk for intracranial atherosclerotic stenosis
por: Liu, Ying, et al.
Publicado: (2019)

Fasting blood glucose and cerebrospinal fluid Alzheimer’s biomarkers in non-diabetic cognitively normal elders: the CABLE study
por: Ou, Ya-Nan, et al.
Publicado: (2020)

Associations of healthy lifestyles with cerebrospinal fluid biomarkers of Alzheimer’s disease pathology in cognitively intact older adults: the CABLE study
por: Hou, Xiao-He, et al.
Publicado: (2021)

Metabolically healthy obesity and risk of stroke: a meta-analysis of prospective cohort studies
por: Ma, Ling-Zhi, et al.
Publicado: (2021)

Toll-like receptor 9 promoter polymorphism is associated with decreased risk of Alzheimer’s disease in Han Chinese
por: Wang, Ying-Li, et al.
Publicado: (2013)

Plasma amyloid, tau, and neurodegeneration biomarker profiles predict Alzheimer's disease pathology and clinical progression in older adults without dementia
por: Shen, Xue‐Ning, et al.
Publicado: (2020)

Association of rs2072446 in the NGFR gene with the risk of Alzheimer's disease and amyloid‐β deposition in the brain
por: He, Chen‐Yang, et al.
Publicado: (2022)

Plasma sex hormone-binding globulin predicts neurodegeneration and clinical progression in prodromal Alzheimer's disease
por: Xu, Wei, et al.
Publicado: (2020)

FDG-PET as an independent biomarker for Alzheimer’s biological diagnosis: a longitudinal study
por: Ou, Ya-Nan, et al.
Publicado: (2019)

Leisure time physical activity and dementia risk: a dose-response meta-analysis of prospective studies
por: Xu, Wei, et al.
Publicado: (2017)

Genome-wide association study identifies CD1A associated with rate of increase in plasma neurofilament light in non-demented elders
por: Wang, Zuo-Teng, et al.
Publicado: (2019)

MS4A6A genotypes are associated with the atrophy rates of Alzheimer's disease related brain structures
por: Ma, Jing, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_tul52ah4vp5dqs6t5a5ra4isu0